Document is current
Any future updates will be listed below
-
Authors
Richmond, Rebecca C. https://orcid.org/0000-0003-0574-5071
Howe, Laurence J. https://orcid.org/0000-0002-2819-9686
Heilbron, Karl
Jones, Samuel https://orcid.org/0000-0003-0153-922X
Liu, Junxi
,
Aslibekyan, Stella
Auton, Adam
Babalola, Elizabeth
Bell, Robert K.
Bielenberg, Jessica
Bryc, Katarzyna
Bullis, Emily
Coker, Daniella
Partida, Gabriel Cuellar
Dhamija, Devika
Das, Sayantan
Elson, Sarah L.
Filshtein, Teresa
Fletez-Brant, Kipper
Fontanillas, Pierre
Freyman, Will
Gandhi, Pooja M.
Heilbron, Karl
Hicks, Barry
Hinds, David A.
Jewett, Ethan M.
Jiang, Yunxuan
Kukar, Katelyn
Lin, Keng-Han
Lowe, Maya
McCreight, Jey C.
McIntyre, Matthew H.
Micheletti, Steven J.
Moreno, Meghan E.
Mountain, Joanna L.
Nandakumar, Priyanka
Noblin, Elizabeth S.
O’Connell, Jared
Petrakovitz, Aaron A.
Poznik, G. David
Schumacher, Morgan
Shastri, Anjali J.
Shelton, Janie F.
Shi, Jingchunzi
Shringarpure, Suyash
Tran, Vinh
Tung, Joyce Y.
Wang, Xin
Wan, Wei
Weldon, Catherine H.
Wilton, Peter
Hernandez, Alejandro
Wong, Corinna
Tchakouté, Christophe Toukam
Wang, Xin https://orcid.org/0000-0001-7242-357X
Weedon, Michael N.
Rutter, Martin K.
Lawlor, Deborah A. https://orcid.org/0000-0002-6793-2262
Davey Smith, George https://orcid.org/0000-0002-1407-8314
Vetter, Céline
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UU_00011)
Cancer Research UK (C18281/A29019)
Alexander von Humboldt-Stiftung
Novo Nordisk UK Research Foundation
British Heart Foundation (CH/F/20/90003)
DH | National Institute for Health Research (NF-0616-10102)
- License Information
-
More Information
Article History
Received: 14 February 2023
Accepted: 30 October 2023
First Online: 13 November 2023
Competing interests
: R.C.R. is an Editorial Board Member for <i>Communications Biology</i>, but was not involved in the editorial review of, nor the decision to publish this article. X.W. and the 23andMe Research Team are employees of 23andMe, Inc. and own stock and/or stock options in 23andMe, Inc. K.H. is a former employee of 23andMe, Inc. and holds stock and/or share options in 23andMe, Inc. L.H. is a current employee and stockholder of GlaxoSmithKline. C.V. is a current employee of IQVIA GmbH. The remaining authors declare no competing interests.
